{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:32:27Z","timestamp":1789587147169,"version":"build-2803163510"},"reference-count":92,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T00:00:00Z","timestamp":1708300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Royal Pharmacists Association of Antwerp (KAVA)"},{"name":"Erasmus Exchange Program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacy"],"abstract":"<jats:p>Background: Medication review is a multifaceted service aimed at optimizing the use of medicines and enhancing the health outcomes of patients. Due to its complexity, it is crucial to clearly describe the service, its variants, and its components to avoid confusion and ensure a better understanding of medication review among healthcare providers. Aim: This study aims to bring clarity to the origins, definitions, abbreviations, and types of medication reviews, together with the primary criteria that delineate key features of this service. Method: A narrative review approach was employed to clarify the diverse terminology associated with \u201cmedication review\u201d services. Relevant references were initially identified through searches on PubMed and Google Scholar, complementing the existing literature known to the authors. Results: The study uncovers a complicated and sometimes convoluted history of \u201cmedication review\u201d in different regions around the world. The initial optimization of medicine use had an economic purpose before evolving subsequently into a more patient-oriented approach. A selection of abbreviations, definitions, and types were outlined to enhance the understanding of the service. Conclusions: The study underscores the urgent need for comprehensive information and standardization regarding the content and quality of the services, collectively referred to as \u201cmedication review\u201d.<\/jats:p>","DOI":"10.3390\/pharmacy12010039","type":"journal-article","created":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T11:23:57Z","timestamp":1708341837000},"page":"39","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Medication Review: What\u2019s in a Name and What Is It about?"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3342-3870","authenticated-orcid":false,"given":"Anneleen","family":"Robberechts","sequence":"first","affiliation":[{"name":"Laboratory of Physiopharmacology, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium"},{"name":"Meduplace, Royal Pharmacists Association of Antwerp (KAVA), 2018 Antwerp, Belgium"},{"name":"Centre for Pharmaceutical Research, Research Group of Clinical Pharmacology and Clinical Pharmacy, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Jette, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Brumer","sequence":"additional","affiliation":[{"name":"Laboratory of Physiopharmacology, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Garcia-Cardenas","sequence":"additional","affiliation":[{"name":"Pharmacy and Pharmaceutical Technology Department, University of Granada, 18071 Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niurka M.","family":"Dupotey","sequence":"additional","affiliation":[{"name":"Independent Researcher, Montreal, QC H8Y 1N6, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4586-6919","authenticated-orcid":false,"given":"Stephane","family":"Steurbaut","sequence":"additional","affiliation":[{"name":"Centre for Pharmaceutical Research, Research Group of Clinical Pharmacology and Clinical Pharmacy, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Jette, Belgium"},{"name":"Department of Hospital Pharmacy, UZ Brussel, Laarbeeklaan 101, 1090 Jette, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3848-8702","authenticated-orcid":false,"given":"Guido R. Y.","family":"De Meyer","sequence":"additional","affiliation":[{"name":"Laboratory of Physiopharmacology, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4488-551X","authenticated-orcid":false,"given":"Hans","family":"De Loof","sequence":"additional","affiliation":[{"name":"Laboratory of Physiopharmacology, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1503\/cmaj.070041","article-title":"Evolution in the practice of pharmacy\u2014Not a revolution!","volume":"176","author":"Pearson","year":"2007","journal-title":"Can. Med. Assoc. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/j.1552-4604.1981.tb05699.x","article-title":"History of clinical pharmacy and clinical pharmacology","volume":"21","author":"Miller","year":"1981","journal-title":"J. Clin. Pharmacol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1054-3589(08)60124-6","article-title":"Drug therapy: The impact of managed care","volume":"44","author":"Hopkins","year":"1998","journal-title":"Adv. Pharmacol."},{"key":"ref_4","first-page":"533","article-title":"Opportunities and responsibilities in pharmaceutical care","volume":"47","author":"Hepler","year":"1990","journal-title":"Am. J. Hosp. Pharm."},{"key":"ref_5","unstructured":"NICE Medicines and Prescribing Centre (UK) (2023, November 02). Medicines Optimisation: The Safe and Effective Use of Medicines to Enable the Best Possible Outcomes, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK355921\/."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2125.2012.04331.x","article-title":"Medication reviews","volume":"74","author":"Blenkinsopp","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2125.2012.04178.x","article-title":"Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: A systematic review","volume":"74","author":"Geurts","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1016\/j.sapharm.2022.01.005","article-title":"Defining the role of pharmacists in addressing the social determinants of health","volume":"18","author":"Kiles","year":"2022","journal-title":"Res. Soc. Adm. Pharm."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1258364","DOI":"10.3389\/fphar.2023.1258364","article-title":"Key elements in the quality assessment of a type 3 medication review","volume":"14","author":"Robberechts","year":"2023","journal-title":"Front. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s11096-022-01494-5","article-title":"Terms used to describe and define activities undertaken as a result of the medication review process: Do they require standardisation? A systematic review","volume":"45","author":"Alharthi","year":"2022","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/jac5.1601","article-title":"Development of clinical pharmacy quality measures: A call to action","volume":"5","author":"Nesbit","year":"2022","journal-title":"J. Am. Coll. Clin. Pharm."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/jrsm.1635","article-title":"Citation tracking for systematic literature searching: A scoping review","volume":"14","author":"Hirt","year":"2023","journal-title":"Res. Synth. Methods"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1345\/aph.1H424","article-title":"Clinical pharmacy and medication safety","volume":"40","author":"Christen","year":"2006","journal-title":"Ann. Pharmacother."},{"key":"ref_14","unstructured":"Strom, B.L. (2005). Pharmacoepidemiology, John Wiley & Sons, Ltd.. [4th ed.]."},{"key":"ref_15","first-page":"257","article-title":"A primer on drug utilization review","volume":"36","author":"Kubacka","year":"1996","journal-title":"J. Am. Pharm. Assoc."},{"key":"ref_16","unstructured":"Lee, P. (1969). Task Force on Prescription Drugs, Final Report."},{"key":"ref_17","unstructured":"Academy of Managed Care Pharmacy (2023, November 24). Drug Utilization Review. AMCP. Available online: https:\/\/www.amcp.org\/about\/managed-care-pharmacy-101\/concepts-managed-care-pharmacy\/drug-utilization-review."},{"key":"ref_18","unstructured":"Peterson, A.M. (2005). Managing Pharmacy Practice. Principles, Strategies, and Systems, CRC Press LLC."},{"key":"ref_19","unstructured":"Patient-Centered Primary Care Collaborative (2023, December 03). The Patient-Centered Medical Home: Integrating Comprehensive Medication Management to Optimize Patient Outcomes Resource Guide. Available online: https:\/\/thepcc.org\/sites\/default\/files\/media\/medmanagement.pdf."},{"key":"ref_20","unstructured":"National Board of Medication Therapy Management, Thomas, D., and Tran, J. (2023, November 10). Medication Therapy Management. National Board of Medication Therapy Management. Available online: https:\/\/nbmtm.org\/mtm-reference\/medication-therapy-management\/."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Kiiski, A., Airaksinen, M., Mantyla, A., Desselle, S., Kumpusalo-Vauhkonen, A., Jarvensivu, T., and Pohjanoksa-Mantyla, M. (2019). An inventory of collaborative medication reviews for older adults\u2014Evolution of practices. BMC Geriatr., 19.","DOI":"10.1186\/s12877-019-1317-6"},{"key":"ref_22","first-page":"688","article-title":"Comparison of Medication Therapy Management Services and Their Effects on Health Care Utilization and Medication Adherence","volume":"25","author":"Ferries","year":"2019","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"American Pharmacists Association, and National Association of Chain Drug Stores Foundation (2008). Medication therapy management in pharmacy practice: Core elements of an MTM service model (version 2.0). J. Am. Pharm. Assoc., 48, 341\u2013353.","DOI":"10.1331\/JAPhA.2008.08514"},{"key":"ref_24","unstructured":"(2023, December 19). The NHS Chronic Medication Service at Your Local Pharmacy. NHS Scotland. Available online: https:\/\/www.communitypharmacy.scot.nhs.uk\/documents\/epharmacy\/cms\/cms_patient_information_leaflet.pdf."},{"key":"ref_25","unstructured":"Pharmacy Programs Administrator (PPA) Australia (2023, October 30). Home Medicines Review. PPA Australia. Available online: https:\/\/www.ppaonline.com.au\/programs\/medication-management-programs\/home-medicines-review."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40266-016-0357-2","article-title":"Pharmacist-Led Home Medicines Review and Residential Medication Management Review: The Australian Model","volume":"33","author":"Chen","year":"2016","journal-title":"Drugs Aging"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s11096-018-0696-7","article-title":"PCNE definition of medication review: Reaching agreement","volume":"40","author":"Hersberger","year":"2018","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s11096-015-0145-9","article-title":"Implementation of medication review with follow-up in a Spanish community pharmacy and its achieved outcomes","volume":"37","author":"Ocampo","year":"2015","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_29","unstructured":"Pharmaceutical Society of New Zealand (PSNZ) (2023, November 22). Introduction to MTA. PSNZ. Available online: https:\/\/www.psnz.org.nz\/Folder?Action=View%20File&Folder_id=96&File=IntroductionToMTA.pdf."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1331\/1544345055001274","article-title":"Definition of medication therapy management: Development of professionwide consensus","volume":"45","author":"Bluml","year":"2005","journal-title":"J. Am. Pharm. Assoc."},{"key":"ref_31","unstructured":"Clyne, W., Blenkinsopp, A., and Seal, R. (2008). A Guide to Medication Review, Keele University."},{"key":"ref_32","unstructured":"The Pharmaceutical Care Network Europe (PCNE) (2013). Statement Medication Review Types According to PCNE, Pharmaceutical Care Network Europe."},{"key":"ref_33","unstructured":"National Health Service (NHS), UK (2023, November 30). New Medicine Service (NMS). NHS UK, Available online: https:\/\/www.nhs.uk\/nhs-services\/prescriptions-and-pharmacies\/pharmacies\/new-medicine-service-nms\/."},{"key":"ref_34","unstructured":"Pharmacy Programs Administrator (PPA) Australia (2023, October 30). Residential Medication Management Review and Quality Use of Medicines. PPA Australia. Available online: https:\/\/www.ppaonline.com.au\/programs\/medication-management-programs\/residential-medication-management-review-and-quality-use-of-medicines."},{"key":"ref_35","unstructured":"National Health Service England (2023, October 30). Structured Medication Reviews and Medicines Optimisation: Guidance. NHS England, Available online: https:\/\/www.england.nhs.uk\/primary-care\/pharmacy\/smr\/."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0160-3450(15)31554-3","article-title":"Compliance-related problems in the ambulatory population","volume":"30","author":"Larrat","year":"1990","journal-title":"Am. Pharm."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/fampra\/16.3.278","article-title":"\u2018Brown bag\u2019 medication reviews as a means of optimizing patients\u2019 use of medication and of identifying potential clinical problems","volume":"16","author":"Nathan","year":"1999","journal-title":"Fam. Pr."},{"key":"ref_38","unstructured":"Carver, N., Jamal, Z., and Dering Anderson, A.M. (2023). StatPearls, StatPearls."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1001\/archinte.1991.00400090107019","article-title":"Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine","volume":"151","author":"Beers","year":"1991","journal-title":"Arch. Intern. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00228-019-02634-z","article-title":"A systematic review and novel classification of listing tools to improve medication in older people","volume":"75","author":"Pazan","year":"2019","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5414\/CPP46072","article-title":"STOPP (Screening Tool of Older Person\u2019s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation","volume":"46","author":"Gallagher","year":"2008","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0895-4356(94)90192-9","article-title":"A summated score for the medication appropriateness index: Development and assessment of clinimetric properties including content validity","volume":"47","author":"Samsa","year":"1994","journal-title":"J. Clin. Epidemiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000521699","article-title":"The Medication Appropriateness Index: A Clinimetric Measure","volume":"91","author":"Hanlon","year":"2022","journal-title":"Psychother. Psychosom."},{"key":"ref_44","unstructured":"International Pharmaceutical Federation (FIP), and World Health Organization (WHO) (2011). Joint FIP\/WHO Guidelines on Good Pharmacy Practice: Standards for Quality of Pharmacy Services."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.sapharm.2014.02.005","article-title":"Medication review practices in European countries","volume":"10","author":"Bulajeva","year":"2014","journal-title":"Res. Soc. Adm. Pharm."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e2019020","DOI":"10.4178\/epih.e2019020","article-title":"Impact of pharmacist-led home medicines review services on drug-related problems among the elderly population: A systematic review","volume":"41","author":"Gudi","year":"2019","journal-title":"Epidemiol. Health"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1331\/1544345055001328","article-title":"Medication therapy management services: A critical review","volume":"45","author":"Lewin","year":"2005","journal-title":"J. Am. Pharm. Assoc."},{"key":"ref_48","first-page":"18","article-title":"Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years","volume":"15","author":"Barnett","year":"2009","journal-title":"J. Manag. Care Pharm."},{"key":"ref_49","unstructured":"Department of Health (2023, November 11). National Service Framework for Older People, Available online: https:\/\/assets.publishing.service.gov.uk\/media\/5a7b4f16e5274a34770ead1c\/National_Service_Framework_for_Older_People.pdf."},{"key":"ref_50","unstructured":"Royal Pharmaceutical Society (2013). Medicines Optimisation: Helping Patients to Make the Most of Medicines, Royal Pharmaceutical Society."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.sapharm.2019.11.002","article-title":"Community pharmacist-led medication review procedures across Europe: Characterization, implementation and remuneration","volume":"16","author":"Soares","year":"2020","journal-title":"Res. Soc. Adm. Pharm."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.sapharm.2016.08.005","article-title":"Pharmacist-led medication review in community settings: An overview of systematic reviews","volume":"13","author":"Jokanovic","year":"2017","journal-title":"Res. Soc. Adm. Pharm."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/bcp.12140","article-title":"A systematic review and meta-analysis of pharmacist-led fee-for-services medication review","volume":"77","author":"Hatah","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_54","unstructured":"National Health Service England (2024, February 09). Summary Care Records (SCR). NHS England, Available online: https:\/\/www.england.nhs.uk\/long-read\/summary-care-records-scr\/#:~:text=The%20NHS%20summary%20care%20record,as%20the%20\u2019source%20record\u2019."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e641","DOI":"10.3399\/BJGP.2022.0014","article-title":"Early implementation of the structured medication review in England: A qualitative study","volume":"72","author":"Madden","year":"2022","journal-title":"Br. J. Gen. Pract."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Kieck, D., Mahalick, L., and Vo, T.T. (2023). Medication-Related Problems Identified and Addressed by Pharmacists Dispensing COVID-19 Antivirals at a Community Pharmacy. Pharmacy, 11.","DOI":"10.3390\/pharmacy11030087"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1177\/0897190020980626","article-title":"Community Pharmacists Roles During the COVID-19 Pandemic","volume":"35","author":"Hess","year":"2022","journal-title":"J. Pharm. Pract."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta6200","article-title":"Clinical medication review by a pharmacist of patients on repeat prescriptions in general practice: A randomised controlled trial","volume":"6","author":"Zermansky","year":"2002","journal-title":"Health Technol. Assess."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Wiffen, P., Mitchell, M., Snelling, M., and Stoner, N. (2007). Oxford Handbook of Clinical Pharmacy, Oxford University Press. [1st ed.].","DOI":"10.1093\/med\/9780198567103.001.0001"},{"key":"ref_60","unstructured":"Medicines Partnership (2023, October 30). What is MR\/Models of MR. Medicines Partnership. Available online: https:\/\/medicines-partnership.org\/medication-review\/welcome\/room-for-review\/what-is-mr."},{"key":"ref_61","unstructured":"Saskatchewan Ministry of Health (2023, December 03). Saskatchewan Medication Assessment Program (SMAP). Procedures and Guidelines for Saskatchewan Pharmacists, Available online: https:\/\/members.skpharmacists.ca\/wp-content\/uploads\/2023\/04\/SMAP-Procedures-and-Guidelines.pdf."},{"key":"ref_62","unstructured":"Ontario Ministry of Health and Long-Term Care (2023, December 03). Professional Pharmacy Services Guidebook 3.0. MedsCheck, Pharmaceutical Opinion and Pharmacy Smoking Cessation Program, Available online: https:\/\/files.ontario.ca\/moh-medscheck-professional-pharmacy-services-guidebook-2016-07-01.pdf."},{"key":"ref_63","unstructured":"(2023, December 03). The Patient Care Process for Delivering Comprehensive Medication Management (CMM): Optimizing Medication Use in Patient-Centered, Team-Based Care Settings. CMM in Primary Care Research Team. Available online: https:\/\/www.accp.com\/docs\/positions\/misc\/CMM_Care_Process.pdf."},{"key":"ref_64","unstructured":"Pharmaceutical Society of Ireland (PSI) (2024, January 14). Guidelines on Counselling and Medicine Therapy Review in the Supply of Prescribed Medicinal Products. Available online: https:\/\/www.thepsi.ie\/Libraries\/Folder_Pharmacy_Practice_Guidance\/01_11_Guidelines_on_Counselling_and_Medicine_Therapy_Review_in_the_Supply_of_Prescribed_Medicinal_Products.sflb.ashx."},{"key":"ref_65","unstructured":"Pharmaceutical Society of Australia (PSA) (2023, December 03). Guidelines for Pharmacists Providing Residential Medication Management Review (RMMR) and Quality Use of Medicines (QUM) services. Available online: https:\/\/www.ppaonline.com.au\/wp-content\/uploads\/2019\/01\/PSA-RMMR-and-QUM-Guidelines.pdf."},{"key":"ref_66","unstructured":"Pharmaceutical Society of Australia (PSA) (2023, December 03). Guidelines for Quality Use of Medicines (QUM) Services. Available online: https:\/\/www.ppaonline.com.au\/wp-content\/uploads\/2020\/04\/PSA-Guidelines-for-Quality-Use-of-Medicines-QUM-services.pdf."},{"key":"ref_67","unstructured":"Pharmaceutical Society of Australia (PSA) (2023, December 03). Guidelines for Comprehensive Medication Management Review. Available online: https:\/\/www.ppaonline.com.au\/wp-content\/uploads\/2020\/04\/PSA-Guidelines-for-Comprehensive-Medication-Management-Reviews.pdf."},{"key":"ref_68","unstructured":"The Royal Dutch Pharmacists Association (KNMP) (2023, December 03). Clinical Medication Review. 2013\u20132020. Available online: https:\/\/www.knmp.nl\/richtlijnen\/medicatiebeoordeling."},{"key":"ref_69","unstructured":"National Health Service (NHS) (2024, February 09). Network Contract Directed Enhanced Service. Structured Medication Reviews and Medicines Optimisation: Guidance, Available online: https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2020\/09\/SMR-Spec-Guidance-2020-21-FINAL-.pdf."},{"key":"ref_70","unstructured":"Department of Health and Aged Care, and Australian Government (2023, December 03). Guiding Principles for Medication Management in the Community, Available online: https:\/\/www.health.gov.au\/sites\/default\/files\/2022-11\/guiding-principles-for-medication-management-in-the-community.pdf."},{"key":"ref_71","unstructured":"Foro de Atenci\u00f3n Farmac\u00e9utica en Farmacia Comunitaria (Foro AF-FC) (2024, January 14). Practical Guide to Clinical Professional Pharmacy Services in Community Pharmacy. Madrid. General Pharmaceutical Council of Spain. Available online: https:\/\/www.farmaceuticos.com\/wp-content\/uploads\/2021\/02\/ON_GUIA_SPFA_FORO_2022_ING_PGs.pdf."},{"key":"ref_72","unstructured":"Huckerby, C., and Jaspal, J. (2023, October 10). Medication Review\u2014Best Practice Guidelines, Available online: https:\/\/www.dudleyformulary.nhs.uk\/download\/286\/medication-review-best-practice-guidelines."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.4103\/jfmpc.jfmpc_237_22","article-title":"Exploring the value of a multidisciplinary-led medication review for elderly individuals at a long-term care facility performed by four different health-care professions in an equal and closely integrated collaboration","volume":"11","author":"Frandsen","year":"2022","journal-title":"J. Fam. Med. Prim. Care"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s11096-023-01541-9","article-title":"Patient experiences and opinions on medication review: A qualitative study","volume":"45","author":"Robberechts","year":"2023","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s11096-020-01224-9","article-title":"Qualitative study of medication review in Flanders, Belgium among community pharmacists and general practitioners","volume":"43","author":"Robberechts","year":"2021","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.healthpol.2015.02.007","article-title":"From \u201cretailers\u201d to health care providers: Transforming the role of community pharmacists in chronic disease management","volume":"119","author":"Mossialos","year":"2015","journal-title":"Health Policy"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/ijpp.12462","article-title":"Community pharmacist-led interventions and their impact on patients\u2019 medication adherence and other health outcomes: A systematic review","volume":"26","author":"Milosavljevic","year":"2018","journal-title":"Int. J. Pharm. Pract."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Radcliffe, E., Servin, R., Cox, N., Lim, S., Tan, Q.Y., Howard, C., Sheikh, C., Rutter, P., Latter, S., and Lown, M. (2023). What makes a multidisciplinary medication review and deprescribing intervention for older people work well in primary care? A realist review and synthesis. BMC Geriatr., 23.","DOI":"10.1186\/s12877-023-04256-8"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"van Nuland, M., Butterhoff, M., Verwijmeren, K., Berger, F., Hogervorst, V.M., de Jonghe, A., and van der Linden, P.D. (2023). Assessment of drug-related problems at the emergency department in older patients living with frailty: Pharmacist-led medication reviews within a geriatric care team. BMC Geriatr., 23.","DOI":"10.1186\/s12877-023-03942-x"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Rojas, E.I., Dupotey, N.M., and De Loof, H. (2023). Comprehensive Medication Management Services with a Holistic Point of View, a Scoping Review. Pharmacy, 11.","DOI":"10.3390\/pharmacy11010037"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Verma, A., Saha, S., Jarl, J., Conlon, E., McGuinness, B., and Trepel, D. (2023). An Overview of Systematic Reviews and Meta-Analyses on the Effect of Medication Interventions Targeting Polypharmacy for Frail Older Adults. J. Clin. Med., 12.","DOI":"10.3390\/jcm12041379"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Huiskes, V.J., Burger, D.M., van den Ende, C.H., and van den Bemt, B.J. (2017). Effectiveness of medication review: A systematic review and meta-analysis of randomized controlled trials. BMC Fam. Pract., 18.","DOI":"10.1186\/s12875-016-0577-x"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1143444","DOI":"10.3389\/fphar.2023.1143444","article-title":"Clinical, economic and humanistic outcomes of medication therapy management services: A systematic review and meta-analysis","volume":"14","author":"Deng","year":"2023","journal-title":"Front. Pharmacol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/ggi.13796","article-title":"Clinical medication review type III of polypharmacy reduced unplanned hospitalizations in older adults: A meta-analysis of randomized clinical trials","volume":"19","author":"Mizokami","year":"2019","journal-title":"Geriatr. Gerontol. Int."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.sapharm.2013.08.006","article-title":"Pharmacist services provided in general practice clinics: A systematic review and meta-analysis","volume":"10","author":"Tan","year":"2014","journal-title":"Res. Soc. Adm. Pharm."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00228-020-02951-8","article-title":"Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: A systematic review of randomized controlled trials","volume":"77","author":"Pazan","year":"2021","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejim.2016.03.007","article-title":"Frailty measurement in research and clinical practice: A review","volume":"31","author":"Dent","year":"2016","journal-title":"Eur. J. Intern. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.puhe.2010.01.002","article-title":"Synthesizing diverse evidence: The use of primary qualitative data analysis methods and logic models in public health reviews","volume":"124","author":"Baxter","year":"2010","journal-title":"Public Health"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/pubmed\/fdu044","article-title":"The appraisal of public health interventions: The use of theory","volume":"37","author":"Threlfall","year":"2015","journal-title":"J. Public Health"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/bcp.12732","article-title":"A systematic review of the emerging de fi nition of \u2018deprescribing\u2019 with network analysis: Implications for future research and clinical practice","volume":"80","author":"Reeve","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1111\/jgs.17894","article-title":"Recommendations for outcome measurement for deprescribing intervention studies","volume":"70","author":"Bayliss","year":"2022","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","article-title":"A new taxonomy for describing and defining adherence to medications","volume":"73","author":"Vrijens","year":"2012","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2226-4787\/12\/1\/39\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:02:26Z","timestamp":1760104946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2226-4787\/12\/1\/39"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,19]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["pharmacy12010039"],"URL":"https:\/\/doi.org\/10.3390\/pharmacy12010039","relation":{},"ISSN":["2226-4787"],"issn-type":[{"value":"2226-4787","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,19]]}}}